Isomorphic labs

A digital biology company founded in 2021, Isomorphic Labs is a subsidiary of Alphabet Inc. that focuses on utilizing artificial intelligence to revolutionize drug discovery processes. By leveraging advanced AI technologies, the company aims to enhance the efficiency and accuracy of identifying potential therapeutic compounds, setting it apart from traditional pharmaceutical research methods. The primary beneficiaries of Isomorphic Labs' innovations are pharmaceutical companies and researchers seeking to expedite and improve the drug development pipeline.